We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 3 (BioSput-Air)

This study has been terminated.
(A lot of patients recruited in our center were already on montelukast treatment. It was not possible to recruit sufficient patients for the study.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01224964
First Posted: October 20, 2010
Last Update Posted: October 23, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Dominque Bullens, Universitaire Ziekenhuizen Leuven
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2014
  Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)